145 related articles for article (PubMed ID: 36099068)
1. Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
Shih YT; Xu Y; Bradley C; Giordano SH; Yao J; Yabroff KR
J Natl Cancer Inst; 2022 Oct; 114(10):1392-1399. PubMed ID: 36099068
[TBL] [Abstract][Full Text] [Related]
2. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
3. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
Narang AK; Nicholas LH
JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
[TBL] [Abstract][Full Text] [Related]
4. Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
Paro A; Hyer JM; Shaikh CF; Pawlik TM
Ann Surg Oncol; 2022 Sep; 29(9):5387-5397. PubMed ID: 35430665
[TBL] [Abstract][Full Text] [Related]
5. Increasing Out-of-Pocket Costs for Neurologic Care for Privately Insured Patients.
Hill CE; Reynolds EL; Burke JF; Banerjee M; Kerber KA; Magliocco B; Esper GJ; Skolarus LE; Callaghan BC
Neurology; 2021 Jan; 96(3):e322-e332. PubMed ID: 33361253
[TBL] [Abstract][Full Text] [Related]
6. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
7. Evaluation of trends in the cost of initial cancer treatment.
Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
[TBL] [Abstract][Full Text] [Related]
8. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
[TBL] [Abstract][Full Text] [Related]
9. The Increasing Financial Burden of Outpatient Elective Surgery for the Privately Insured.
Billig JI; Lan WC; Chung KC; Kuo CF; Sears ED
Ann Surg; 2020 Sep; 272(3):530-536. PubMed ID: 32740255
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Patient Out-of-Pocket Cost for Radiation Therapy by Insurance Type and Treatment Modality.
Chen LW; Cao Y; D'Rummo K; Shen X
Pract Radiat Oncol; 2022; 12(6):e481-e485. PubMed ID: 35447387
[TBL] [Abstract][Full Text] [Related]
11. Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US.
Zaorsky NG; Khunsriraksakul C; Acri SL; Liu DJ; Ba DM; Lin JL; Liu G; Segel JE; Drabick JJ; Mackley HB; Leslie DL
JAMA Netw Open; 2021 Oct; 4(10):e2127784. PubMed ID: 34613403
[TBL] [Abstract][Full Text] [Related]
12. The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis.
Lindsay D; Schofield P; Nabukalu D; Roberts MJ; Yaxley J; Quinn S; Richards N; Frydenberg M; Gardiner R; Lawrentschuk N; Juraskova I; Murphy DG; Gordon LG
Aust Health Rev; 2024 Feb; 48():172-181. PubMed ID: 38342484
[TBL] [Abstract][Full Text] [Related]
13. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
Lu CY; Zhang F; Wagner AK; Nekhlyudov L; Earle CC; Callahan M; LeCates R; Xu X; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Aug; 171(1):235-242. PubMed ID: 29754304
[TBL] [Abstract][Full Text] [Related]
14. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
[TBL] [Abstract][Full Text] [Related]
15. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
16. Increased healthcare costs by later stage cancer diagnosis.
McGarvey N; Gitlin M; Fadli E; Chung KC
BMC Health Serv Res; 2022 Sep; 22(1):1155. PubMed ID: 36096813
[TBL] [Abstract][Full Text] [Related]
17. Patient Out-of-Pocket Cost Burden With Elective Orthopaedic Surgery.
Durand WM; Ortiz-Babilonia CD; Badin D; Wang KY; Jain A
J Am Acad Orthop Surg; 2022 Jul; 30(14):669-675. PubMed ID: 35797680
[TBL] [Abstract][Full Text] [Related]
18. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
[TBL] [Abstract][Full Text] [Related]
19. Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component.
Ibarrondo O; Lizeaga G; Martínez-Llorente JM; Larrañaga I; Soto-Gordoa M; Álvarez-López I
Gac Sanit; 2022; 36(3):246-252. PubMed ID: 33612313
[TBL] [Abstract][Full Text] [Related]
20. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
Chastek B; Kulakodlu M; Valluri S; Seal B
Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
